Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT07538583
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT07538583 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2027-01-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |